EGFR and colorectal carcinoma: Moreover, NK cells can contribute to CAF inhibition when ADCC-competent CAF-targeting monoclonal antibodies are employed, as demonstrated in models of CRC where CAFs express abundant epidermal growth factor receptor (EGFR) levels [228].